Foundayo and High Blood Pressure: What to Expect
Foundayo tends to lower blood pressure rather than raise it. In phase 3 trials, average systolic blood pressure fell more on Foundayo than on placebo, which is what you would expect from a weight-management treatment that helps with weight loss.
There is a second finding alongside it that gets far less attention. Foundayo produced a small average increase in heart rate. Lower blood pressure and a slightly faster pulse are not a contradiction, and the sections below explain how these changes fit together, how Foundayo may interact with blood pressure medicines, how to monitor readings at home, and when low or high readings mean you should get medical advice.
This page is for adults in the UK who are considering or using Foundayo for weight management, especially if you have high blood pressure, are worried about hypertension, or already take blood pressure tablets. The group that needs to read this carefully is not people worried the medicine will automatically push blood pressure up. It is people whose medication may need closer monitoring as weight comes down, because a dose that was correct in January can be too much by June.
Key things to know
- Foundayo is the brand name for orforglipron, licensed by the MHRA on 10 August 2026 for weight management in adults.
- In one phase 3 trial, average systolic blood pressure fell by 6.4 mmHg on Foundayo against 1.4 mmHg on placebo. In a trial in people with type 2 diabetes, the figures were 4.6 mmHg against 1.5 mmHg.
- Foundayo produced a mean increase in heart rate of around 4 to 5 beats per minute from baseline, against about 0.5 beats per minute on placebo.
- Low blood pressure was reported in 2% of people on Foundayo against 0.5% on placebo, and it was more common in those already taking blood pressure medicine.
- High blood pressure is a weight related condition, so it can be the qualifying factor for people with a BMI between 27 and 30. It is also a major risk factor for cardiovascular diseases and contributes to overall cardiovascular risk.
- If you take blood pressure medicine, monitor at home and keep your prescriber informed. Your treatment may need reviewing as your weight changes.
- A clinic blood pressure of 180/120 mmHg or higher needs prompt clinical assessment. Same-day specialist assessment is recommended when there are signs of accelerated hypertension or potentially life-threatening symptoms.
- No dedicated cardiovascular outcomes trial has been published for Foundayo , so its long term effect on heart and circulatory events is not established.
Does Foundayo raise or lower blood pressure?
It lowers it, on average, by a modest amount. This effect is typically seen alongside a reduced calorie diet and increased physical activity as part of a comprehensive treatment plan for chronic weight management. Foundayo is an oral GLP-1 receptor agonist authorised in the UK for weight management alongside a reduced-calorie diet and increased physical activity. Foundayo is taken once daily and can be taken with or without food.
Common gastrointestinal side effects include nausea, diarrhoea, vomiting and constipation. More serious problems, such as pancreatitis, severe gastrointestinal reactions or kidney injury related to dehydration, require medical attention.
Foundayo is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or in people with multiple endocrine neoplasia syndrome type 2 (MEN 2). The starting dose is typically low and gradually increased to the highest dose based on tolerance and response, with monitoring for drug interactions and other practical challenges patients face during treatment.
What the trials measured
In the phase 3 programme, these outcomes were assessed over 72 weeks, with systolic blood pressure measured alongside weight in the clinical trials. Systolic pressure is the first and larger of the two numbers in a reading, and it represents the pressure in your arteries as the heart beats.
| Trial population | Average systolic change on Foundayo | Average systolic change on placebo |
|---|---|---|
| Adults without type 2 diabetes | Fall of 6.4 mmHg | Fall of 1.4 mmHg |
| Adults with type 2 diabetes | Fall of 4.6 mmHg | Fall of 1.5 mmHg |
Read these as averages rather than as what will happen to you. Some people in those trials will have seen a larger fall and some none at all. Results vary between individuals.
Put in context, a reduction of several mmHg in systolic pressure is clinically meaningful across a population, but it is not a substitute for blood pressure treatment. Nobody should stop or reduce blood pressure medicine because they have started Foundayo .
Why blood pressure falls
The fall in blood pressure is likely to be related, at least in part, to weight loss. Weight reduction can improve several factors that influence blood pressure, including kidney sodium handling and vascular and hormonal pathways.
Carrying excess weight raises blood pressure through several routes at once: more blood volume to circulate, changes in how the kidneys handle sodium, and hormonal signals from fat tissue that affect vessel tone. Reducing weight eases those pressures, which is why weight loss by any method tends to bring blood pressure down. Body weight reduction is also commonly linked with reductions in waist circumference and triglycerides.
Foundayo and heart rate
Foundayo produced a mean increase in heart rate of around 4 to 5 beats per minute from baseline in trials, compared with roughly half a beat per minute on placebo. Across the trial programme, average pulse increases ran from about 2.8 to 4.6 beats per minute.
A small increase in pulse was observed in clinical trials of Foundayo . For many people it is not noticeable and not a problem. It is also not the same thing as blood pressure, which is why a reading can show a lower pressure and a faster pulse on the same day without either being an error.
Can you take Foundayo if you have high blood pressure?
Usually yes, and for some people high blood pressure is the reason they qualify.
The weight management licence covers adults with obesity, or overweight adults with a weight related health condition or weight related complications. High blood pressure is one of those conditions, alongside type 2 diabetes, sleep apnoea and raised cholesterol. So someone with a BMI of 28 and treated hypertension may be eligible where someone with a BMI of 28 and no such condition is not.
Having high blood pressure does not, by itself, rule out treatment with Foundayo . It does make monitoring more important, and it means your consultation needs the full picture: your readings, every blood pressure medicine you take, and who manages that treatment.
Treatment suitability depends on an individual clinical assessment, and a prescriber may want recent readings before making a decision. If you have never checked at home, the monitoring section below is the place to start, and weight loss treatment eligibility covers what an assessment looks at more broadly.
Foundayo alongside blood pressure medicines
This is the section that matters if you already take something for your blood pressure.
Foundayo is the oral GLP-1 receptor agonist available. It offers a convenient once daily pill option. This flexibility is a significant advantage for people managing both the clinical realities of obesity treatment and hypertension.
When combined with blood pressure medicines such as ACE inhibitors, calcium channel blockers, or diuretics, careful monitoring is essential. These medications are commonly prescribed to manage high blood pressure, which is a major risk factor for cardiovascular diseases and weight related medical problems. Foundayo ’s weight reduction long term effect can lead to changes in blood pressure, and prescriptions accepted immediately by healthcare professionals should include a full review of your medication regimen.
Significant vomiting or diarrhoea can lead to dehydration and, in some people, kidney problems. The prescribing information recommends monitoring renal function when adverse reactions could lead to volume depletion. Other serious or persistent symptoms should be discussed promptly with a healthcare professional.
The over-treatment problem
Low blood pressure was reported in 2% of people taking Foundayo against 0.5% on placebo, and it occurred more often in those already on blood pressure treatment.
The mechanism is simple once you see it. Your blood pressure medicine was prescribed for the person you were at the time, at the weight you were then. As weight falls, your blood pressure tends to fall with it. The medicine keeps working at the same strength against a problem that has shrunk. The result can be readings that are lower than intended, and symptoms that go with it.
This is not a reason to avoid treatment. It is a reason to measure, and to make sure someone is looking at those numbers as you go. A dose that needs reviewing is a sign the weight loss is working, not a sign something has gone wrong.
Medicines that need particular attention
The medicine groups below are common, and each interacts with weight loss treatment in its own way. None of this is a reason to change anything yourself.
| Medicine group | Example | What to watch for |
|---|---|---|
| Calcium channel blockers | Amlodipine | Readings drifting below target as weight falls, dizziness on standing |
| ACE inhibitors | Ramipril | Kidney function if you have vomiting or diarrhoea, alongside falling readings |
| Angiotensin receptor blockers | Losartan | Similar considerations to ACE inhibitors |
| Diuretics | Indapamide, bendroflumethiazide | Fluid and salt balance, particularly during digestive side effects |
| Beta blockers | Bisoprolol | These slow the pulse, which can mask a rise in heart rate |
Tell your prescriber every one of these that you take, by name. Weight management treatment and blood pressure treatment are often managed by different people, and the connection between them only gets made if you make it.
Dehydration, kidney function, food or water restrictions and blood pressure medicines
This combination deserves particular attention because vomiting or diarrhoea can cause fluid loss, which may affect kidney function and blood pressure.
Digestive side effects such as nausea, diarrhoea, vomiting and constipation are common with Foundayo , particularly during dose escalation. Significant vomiting or diarrhoea can cause dehydration and may affect kidney function.
Dehydration alone can affect kidney function. Combined with medicines that act on the kidneys and on fluid balance, such as ACE inhibitors, angiotensin receptor blockers and diuretics, the risk increases. Monitoring of kidney function is recommended for people who experience significant digestive side effects on this treatment.
Signs your blood pressure has dropped too low
Blood pressure that falls below where it should be produces recognisable symptoms, and they are easy to mistake for side effects of the weight loss treatment itself.
- Dizziness or light headedness, particularly when standing up
- Feeling faint, or actually fainting
- Blurred vision that comes and goes
- Unusual tiredness or weakness
- Nausea, which overlaps confusingly with the digestive side effects
- Difficulty concentrating
If these are happening, check your blood pressure rather than guessing. Take the reading while the symptoms are present if you can, and take one after standing as well as sitting, because a drop on standing is a common pattern. Then contact whoever manages your blood pressure treatment with the numbers rather than the symptoms alone.
How to monitor blood pressure at home properly
Home readings are often taken in a way that produces numbers nobody can use. The method below is the one NICE specifies, and following it turns your readings into something a clinician can act on.
- Sit down and rest for a few minutes before you start, with your back supported and your arm supported at heart height.
- Take two consecutive measurements, at least one minute apart, seated.
- Record blood pressure twice each day, ideally once in the morning and once in the evening.
- Continue for at least four days, and ideally seven.
- Discard every reading from the first day.
- Average all the remaining measurements. That average is the number that matters, not any single reading.
A few practical points. Use a validated upper arm monitor with a cuff that fits, because a cuff that is too small reads high. Avoid caffeine and exercise in the half hour before measuring. Do not repeat a reading you dislike until it improves, because that produces a record of your calmest moments rather than your blood pressure. And write down every number, including the ones you did not want.
The numbers that matter
These are the thresholds NICE uses, and knowing them lets you interpret your own readings instead of worrying about them.
| Category | Clinic reading | Home or ambulatory average |
|---|---|---|
| Suspected high blood pressure | 140/90 mmHg or higher | Confirm with home or ambulatory monitoring |
| Stage 1 | 140/90 to 159/99 mmHg | 135/85 to 149/94 mmHg |
| Stage 2 | 160/100 mmHg or higher | 150/95 mmHg or higher |
| Severe hypertension | ≥180/120 mmHg | Prompt assessment. Same-day specialist review if concerning signs/symptoms are present |
Treatment targets are separate from diagnostic thresholds. For adults under 80, the clinic target is below 140/90 mmHg, or below 135/85 mmHg using home or ambulatory readings. For adults aged 80 and over, the clinic target is below 150/90 mmHg, or below 145/85 mmHg on home or ambulatory readings. Your own target may differ depending on your circumstances, which is a question for the clinician managing it.
When to see a doctor about blood pressure
A clinic reading of 180/120 mmHg or higher needs prompt clinical assessment. Same-day specialist assessment is particularly important if it is accompanied by symptoms or signs suggesting acute organ damage, such as chest pain, new confusion, signs of heart failure or acute kidney injury.
Seek urgent medical attention if a reading that high comes with any of the following: new confusion, chest pain, signs of heart failure such as sudden breathlessness or swelling, or symptoms suggesting a kidney problem. Visual symptoms alongside very high readings also need urgent assessment.
Arrange a routine appointment, rather than an urgent one, if your home average sits above the thresholds in the table, if your readings have changed direction since starting weight management treatment, if you are getting dizzy or faint, or if your resting pulse is consistently higher than it used to be.
The limits of what is known
Being clear about the limits is part of reading this properly.
No dedicated cardiovascular outcomes trial has been published for Foundayo . That means the trial evidence shows an effect on blood pressure as a measurement, but it does not establish what the medicine does to the rate of heart attacks, strokes or other circulatory events over time. Those are different questions and they need their own trials.
The blood pressure findings also come from trial populations with their own entry criteria, so they describe what happened in those groups rather than what will happen to any individual. And the phase 3 programme ran to 72 weeks, which tells you nothing about year four.
Medical Disclaimer
This article is general information about prescription only medicine and is not medical advice. It does not replace an assessment by a qualified healthcare professional who knows your medical history, and it should not be used to interpret your own readings in place of clinical advice. Foundayo should only be used under the supervision of an appropriately qualified prescriber, and results vary between individuals.
Never start, stop or change a blood pressure medicine on your own. Always read the patient information leaflet supplied with each of your medicines and follow the advice your prescriber gives you. Seek same day medical review for a reading of 180/120 mmHg or higher, and urgent attention if it comes with confusion, chest pain, sudden breathlessness or visual symptoms. Suspected side effects can be reported through the MHRA Yellow Card scheme.



